Actively Recruiting
Noninvasive Ultrasound Assessment of Detrusor Dysfunction
Led by Mayo Clinic · Updated on 2026-03-27
2023
Participants Needed
1
Research Sites
52 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are evaluating a new ultrasound method called Quantitative Ultrasound Bladder Vibrometry (QUBV) to detect abnormal bladder function, specifically focusing on detrusor overactivity and benign prostatic hyperplasia (BPH) treatment selection. This observational study aims to assess how well QUBV works as a noninvasive tool compared to urodynamic studies, which are part of participants' regular clinical care. Participants will undergo QUBV ultrasound at the same time as their scheduled urodynamic study or selective photovaporization of the prostate, depending on their diagnosis and treatment plan. The study will include adults aged 18 to 90 years who are already scheduled for these procedures as part of their clinical care. The research will not involve experimental treatments but will observe and compare QUBV results with standard diagnostic methods. During the study, researchers will measure the accuracy of QUBV in determining detrusor pressure and in selecting BPH patients for surgery. Data will be collected up to study completion, averaging one year. Participants will continue with their usual care, and the study involves no additional interventions beyond the ultrasound measurement performed alongside routine procedures.
CONDITIONS
Brief Title
Noninvasive Ultrasound Assessment of Detrusor Dysfunction
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age over 18 years and scheduled to undergo urodynamic study for bladder dysfunction, overactive bladder, or BPH with urinary obstruction
- Age over 45 years and scheduled for selective photovaporization of the prostate
You will not qualify if you...
- Obesity with body mass index over 35 kg/m2
- Known neurological diseases impacting bladder function such as spinal cord injury, multiple sclerosis, Parkinson's disease, or prior cerebrovascular accident
- Previous pelvic radiation therapy
- Previous radical pelvic surgery such as for uterine or colorectal cancer
- Prior bladder surgery including prostate resection
- Pregnant or breast-feeding women
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Up to study completion, an average of 1 year
Participants undergo a quantitative ultrasound bladder vibrometry (QUBV) performed at the same time as a urodynamic study as part of their regular clinical care to assess detrusor overactivity and aid in treatment selection.
1 visit (in-person)
Duration - Up to study completion, an average of 1 year
Participants are observed over time to evaluate the accuracy of ultrasound vibrometry for measuring bladder function and selecting appropriate treatment.
Follow-up visits as part of routine clinical care
Trial Site Locations
Total: 1 location
1
Mayo Clinic
Rochester, Minnesota, United States, 55905
Actively Recruiting
Research Team
A
Azra Alizad, MD
K
Kathryn (Katie) Barthels
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here